This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders Love Right Now

Horizon Pharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Another stock that insiders are finding attractive here is biotechnology and drugs player Horizon Pharma (HZNP - Get Report), which develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Insiders are sniffing out some deep value here, since shares are down by a whopping 60% in the last three months. MP/>Horizon Pharma has a market cap of $107.44 million and an enterprise value of $100.17 million. This stock trades at a fair valuation, with a price-to-sales of 11.07 and a price-to-book of 1.94. Its estimated growth rate for this year is -22.7%, and for next year it's pegged at 48.3%. This is barley a cash-rich company, since the total cash position on its balance sheet is $63.46 million and its total debt is $51.12 million.

A director just bought 575,356 shares, or about $2 million worth of stock, at $3.49 per share.

From a technical perspective, HZNP is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock has been destroyed by the sellers during the last three months, with shares plunging from its high of $8.72 to its recent low of $3.15 a share.

During that sharp move lower, shares of HZNP have been consistently making lower highs and lower lows, which is bearish technical price action. This stock also recently gapped down from around $4.50 to $3.50 a share with heavy volume.

If you're in the bull camp on HZNP, then I would only look for long-biased trades if it can manage to break out above some near-term overhead resistance at $3.53 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.3 million shares. If we get that breakout soon, then HZNP could re-fill that gap from September that started near $4.50 a share.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AGCO $53.47 0.21%
DVA $73.90 -1.18%
HZNP $15.37 -0.84%
MCF $12.58 1.45%
RSG $47.07 -0.38%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs